Mevacor OTC opinions
This article was originally published in The Tan Sheet
Executive Summary
American Pharmacists Association supports a "strong role" for pharmacists if an Rx-to-OTC switch of lovastatin 20 mg were to be approved, former APhA President Janet Engle says Jan. 14. An APhA task force developed the "pharmacy care OTC" category for drugs to treat chronic, asymptomatic conditions last fall (1"The Tan Sheet" Nov. 8, 2004, p. 10). J&J/Merck says OTC Mevacor should be sold only in retail outlets with a pharmacy. FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees voted 20-3 against the switch...
You may also be interested in...
“Pharmacy Care” OTC Category Considered By APhA Task Force
A new category of "pharmacy care" drugs could broaden access to certain over-the-counter drugs, according to the American Pharmacists Association
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.